These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3163042)

  • 21. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adynamic bone disease in kidney failure. Role of aluminum].
    Cohen-Solal ME; Sebert JL; Morinière P; Fournier A
    Rev Rhum Ed Fr; 1993 May; 60(5):361-4. PubMed ID: 8167643
    [No Abstract]   [Full Text] [Related]  

  • 23. [Indications for desferrioxamine in patients with chronic renal insufficiency treated by dialysis].
    Simon P
    Nephrologie; 1986; 7(5):177-80. PubMed ID: 3822038
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and treatment of aluminium overload in end-stage renal failure patients. Consensus conference. Paris, France, 27 June 1992.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-54. PubMed ID: 8389014
    [No Abstract]   [Full Text] [Related]  

  • 25. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Contrib Nephrol; 1988; 64():134-43. PubMed ID: 3180820
    [No Abstract]   [Full Text] [Related]  

  • 26. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
    Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
    [No Abstract]   [Full Text] [Related]  

  • 27. Aluminium retention and toxicity in chronic renal failure.
    Thurston H; Gilmore GR; Swales JD
    Lancet; 1972 Apr; 1(7756):881-3. PubMed ID: 4111831
    [No Abstract]   [Full Text] [Related]  

  • 28. Aluminum kinetics of the REDY system: a study of the impact of deferoxamine therapy.
    Culpepper CP; Cummings R; Westervelt FB; Savory J; Wills MR
    Trans Am Soc Artif Intern Organs; 1983; 29():76-80. PubMed ID: 6673321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Myopathies in chronic renal failure patients on dialysis].
    Henning HV
    Dtsch Med Wochenschr; 1996 Jan; 121(4):115. PubMed ID: 8631240
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of desferrioxamine in the treatment of dialysis encephalopathy.
    Ackrill P; Ralston AJ; Day JP
    Kidney Int Suppl; 1986 Feb; 18():S104-7. PubMed ID: 3457985
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperparathyroidism and bone aluminum deposits may coexist.
    Olmer M; Berland Y; Toga M; Charhon S
    Contrib Nephrol; 1985; 49():38-44. PubMed ID: 3830569
    [No Abstract]   [Full Text] [Related]  

  • 32. Aluminum-associated bone disease: what's in a name?
    Quarles LD; Gitelman HJ; Drezner MK
    J Bone Miner Res; 1986 Oct; 1(5):389-90. PubMed ID: 3503553
    [No Abstract]   [Full Text] [Related]  

  • 33. Aluminum and the pathogenesis of dialysis encephalopathy.
    Arieff AI
    Am J Kidney Dis; 1985 Nov; 6(5):317-21. PubMed ID: 3904424
    [No Abstract]   [Full Text] [Related]  

  • 34. Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.
    Netter P; Kessler M; Burnel D; Hutin MF; Delones S; Benoit J; Gaucher A
    J Rheumatol; 1984 Feb; 11(1):66-70. PubMed ID: 6699835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aluminum loading in children with chronic renal failure.
    Sedman AB; Miller NL; Warady BA; Lum GM; Alfrey AC
    Kidney Int; 1984 Aug; 26(2):201-4. PubMed ID: 6503137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful treatment of progressive dialysis encephalopathy. Case report].
    Weiland P; Köhler M; Glatzel E
    Z Urol Nephrol; 1985 Jul; 78(7):387-93. PubMed ID: 4050157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aluminum in tissues.
    Van de Vyver FL; De Broe ME
    Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum aluminium measurements in renal bone disease.
    Lancet; 1983 May; 1(8334):1168-9. PubMed ID: 6133187
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible aluminum intoxication.
    Nutr Rev; 1976 Jun; 34(6):166-7. PubMed ID: 781553
    [No Abstract]   [Full Text] [Related]  

  • 40. [Iatrogenic aluminum osteopathy in a uremic infant].
    Koch H; Reich H; Franke D; Delling G
    Monatsschr Kinderheilkd; 1986 May; 134(5):279-81. PubMed ID: 3724766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.